Want to see HK:2211 full AI Analyst Report?
2211 Stock Chart & Stats
HK$1.67
-HK$0.03(-16.67%)
At close: 4:00 PM EST
HK$1.67
-HK$0.03(-16.67%)
Day’s Range― - ―
52-Week RangeHK$0.42 - HK$5.36
Previous CloseN/A
Volume23.45M
Average Volume (3M)554.01K
Market Cap
HK$75.17M
Enterprise ValueHK$7.54M
Total Cash (Recent Filing)HK$95.07M
Total Debt (Recent Filing)HK$64.73M
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Sep 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding110,546,220
10 Day Avg. Volume803,972
30 Day Avg. Volume554,009
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.27
Price to Sales (P/S)0.12
P/FCF Ratio-1.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance-sheet FlexibilityA very low debt-to-equity (~0.08) provides durable financial flexibility: it reduces near-term default risk, preserves borrowing capacity, and gives management time to execute recovery plans or raise capital without immediate solvency pressure, supporting viability over months.
Improved Gross MarginsMaterial gross margin improvement from prior weak levels indicates better unit economics and cost control at the production or product level. If revenue stabilizes, higher gross margins create a clearer path to sustained operating leverage and eventual profitability over the medium term.
Historical Near-breakeven YearA roughly breakeven operating result in FY2024 shows the business can, under certain conditions, reach near-profitability. This suggests structural cost bases and operational levers exist that management can reapply to pursue a durable recovery if revenue trends reverse.
Bears Say
Shrinking RevenueA multi-year revenue decline (≈24% in FY2025 following FY2024 drops) is a structural headwind: it reduces scale, undermines pricing power, and prevents fixed-cost absorption. Without sustained top-line stabilization, margin gains won’t convert into durable profitability.
Persistent Negative Cash GenerationConsistently negative operating and free cash flow means the business is not self-funding; this creates ongoing reliance on external financing or asset draws. Over months, continuous burn pressures liquidity, limits reinvestment, and raises execution risk for recovery plans.
Inconsistent Profitability And Equity ErosionNegative ROE and declining equity reflect cumulative losses and capital erosion, which reduce financial resilience. Over the medium term this impairs the company’s ability to absorb shocks, invest in growth, and deliver shareholder returns without external recapitalization.
Universal Health International Group Holding Ltd. News
2211 FAQ
What was Universal Health International Group Holding Ltd.’s price range in the past 12 months?
Universal Health International Group Holding Ltd. lowest stock price was HK$0.41 and its highest was HK$5.36 in the past 12 months.
What is Universal Health International Group Holding Ltd.’s market cap?
Universal Health International Group Holding Ltd.’s market cap is HK$75.17M.
When is Universal Health International Group Holding Ltd.’s upcoming earnings report date?
Universal Health International Group Holding Ltd.’s upcoming earnings report date is Sep 29, 2026 which is in 53 days.
How were Universal Health International Group Holding Ltd.’s earnings last quarter?
Universal Health International Group Holding Ltd. released its earnings results on Feb 27, 2026. The company reported -HK$0.068 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.068.
Is Universal Health International Group Holding Ltd. overvalued?
According to Wall Street analysts Universal Health International Group Holding Ltd.’s price is currently Overvalued.
Does Universal Health International Group Holding Ltd. pay dividends?
Universal Health International Group Holding Ltd. pays a Quarterly dividend of HK$0.15 which represents an annual dividend yield of N/A. See more information on Universal Health International Group Holding Ltd. dividends here
What is Universal Health International Group Holding Ltd.’s EPS estimate?
Universal Health International Group Holding Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Universal Health International Group Holding Ltd. have?
Universal Health International Group Holding Ltd. has 110,546,220 shares outstanding.
What happened to Universal Health International Group Holding Ltd.’s price movement after its last earnings report?
Universal Health International Group Holding Ltd. reported an EPS of -HK$0.068 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.538%.
Which hedge fund is a major shareholder of Universal Health International Group Holding Ltd.?
Currently, no hedge funds are holding shares in HK:2211
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Universal Health International Group Holding Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.98%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-16.35%
Trailing 12-Months
Company Description
Universal Health International Group Holding Ltd.
Operating as an investment holding company, Universal Health International Group Holding Limited specializes in the wholesale, retail, and distribution of a comprehensive range of pharmaceutical and healthcare products across China's northeastern region. Its extensive offerings span both Western and traditional Chinese medicines, including patent medicines, chemical preparations, antibiotics, biochemical and biological drugs, traditional Chinese medicine decoction pieces, protein assimilation preparations, peptide hormones, and blood products. The company also supplies medical equipment, disinfection products, nutritional and prepackaged foods, health care items, cosmetics, daily necessities, and specific consumer goods such as family planning supplies (e.g., contraceptives) and infant formula milk powder. Furthermore, Universal Health International Group Holding Limited provides storage services to its varied clientele, which includes pharmaceutical retailers, hospitals, clinics, and distributors. Founded in 1998, the enterprise was formerly known as Jintian Pharmaceutical Group Limited until its rebranding in July 2015, and its corporate headquarters are located in Shenyang, People's Republic of China.
Universal Health International Group Holding Ltd. (2211) Earnings & Revenues
Technical Analysis
EC Healthcare
―
Mediwelcome Healthcare Management & Technology Inc.
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―